How big is the generic drugs market?

Following North America Europe is the second largest consumption place with the consumption market share of 18.Market Analysis and Insights Global Generic Drugs MarketThe global Generic Drugs market size is projected to reach US 505790 million by 2027 from US 281010 million in 2020 at a CAGR of 8.3 during 20212027.With industrystandard accuracy in analy.

Who are the key players in the generic drugs market?

Some of the key players are Sandoz Inc, TEVA, Novartis, Novartis AG, Others.

Global Generic Drugs Market Size Status and Forecast 2022

BUY CHAPTERS

Global Generic Drugs Market Research Report 2023

Code: QYRE-Auto-32W9027

Report

January 2023

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Generic Drugs Market Size

The global Generic Drugs market was valued at US$ 341700 million in 2022 and is anticipated to reach US$ 551330 million by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029.

Generic Drugs Market

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.

North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Generic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Drugs.

The Generic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Generic Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Generic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Generic Drugs Market Report

Report Metric	Details
Report Name	Generic Drugs Market
Accounted market size in 2022	US$ 341700 in million
Forecasted market size in 2029	US$ 551330 million
CAGR	8.3%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Prescription Non-Prescription Drugs
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi, Aurobindo, Lupin, Dr. Reddy's, Apotex, Cipla, ENDO (Par Pharmaceutical), Stada Arzneimittel, Krka Group, Nichi-Iko Pharmaceutical, Valeant, Zydus Cadila, Hikma, Pharmaniaga Berhad, Hovid Berhad, Duopharma Biotech, Kotra Pharma, HOE Pharmaceutical, Y.S.P. Industries
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Generic Drugs Market market growing?

Ans: The Generic Drugs Market market witnessing a CAGR of 8.3% during the forecast period 2022-2029.

What is the Generic Drugs Market market size in 2029?

Ans: The global Generic Drugs market was valued at US$ 341700 million in 2022 and is anticipated to reach US$ 551330 million by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Generic Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Prescription

1.2.3 Non-Prescription Drugs

1.3 Market by Application

1.3.1 Global Generic Drugs Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Generic Drugs Market Perspective (2018-2029)

2.2 Generic Drugs Growth Trends by Region

2.2.1 Global Generic Drugs Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Generic Drugs Historic Market Size by Region (2018-2023)

2.2.3 Generic Drugs Forecasted Market Size by Region (2024-2029)

2.3 Generic Drugs Market Dynamics

2.3.1 Generic Drugs Industry Trends

2.3.2 Generic Drugs Market Drivers

2.3.3 Generic Drugs Market Challenges

2.3.4 Generic Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Generic Drugs Players by Revenue

3.1.1 Global Top Generic Drugs Players by Revenue (2018-2023)

3.1.2 Global Generic Drugs Revenue Market Share by Players (2018-2023)

3.2 Global Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Generic Drugs Revenue

3.4 Global Generic Drugs Market Concentration Ratio

3.4.1 Global Generic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Generic Drugs Revenue in 2022

3.5 Generic Drugs Key Players Head office and Area Served

3.6 Key Players Generic Drugs Product Solution and Service

3.7 Date of Enter into Generic Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Generic Drugs Breakdown Data by Type

4.1 Global Generic Drugs Historic Market Size by Type (2018-2023)

4.2 Global Generic Drugs Forecasted Market Size by Type (2024-2029)

5 Generic Drugs Breakdown Data by Application

5.1 Global Generic Drugs Historic Market Size by Application (2018-2023)

5.2 Global Generic Drugs Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Generic Drugs Market Size (2018-2029)

6.2 North America Generic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Generic Drugs Market Size by Country (2018-2023)

6.4 North America Generic Drugs Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Generic Drugs Market Size (2018-2029)

7.2 Europe Generic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Generic Drugs Market Size by Country (2018-2023)

7.4 Europe Generic Drugs Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Generic Drugs Market Size (2018-2029)

8.2 Asia-Pacific Generic Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Generic Drugs Market Size by Region (2018-2023)

8.4 Asia-Pacific Generic Drugs Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Generic Drugs Market Size (2018-2029)

9.2 Latin America Generic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Generic Drugs Market Size by Country (2018-2023)

9.4 Latin America Generic Drugs Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Generic Drugs Market Size (2018-2029)

10.2 Middle East & Africa Generic Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Generic Drugs Market Size by Country (2018-2023)

10.4 Middle East & Africa Generic Drugs Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Teva

11.1.1 Teva Company Detail

11.1.2 Teva Business Overview

11.1.3 Teva Generic Drugs Introduction

11.1.4 Teva Revenue in Generic Drugs Business (2018-2023)

11.1.5 Teva Recent Development

11.2 Novartis - Sandoz

11.2.1 Novartis - Sandoz Company Detail

11.2.2 Novartis - Sandoz Business Overview

11.2.3 Novartis - Sandoz Generic Drugs Introduction

11.2.4 Novartis - Sandoz Revenue in Generic Drugs Business (2018-2023)

11.2.5 Novartis - Sandoz Recent Development

11.3 Mylan

11.3.1 Mylan Company Detail

11.3.2 Mylan Business Overview

11.3.3 Mylan Generic Drugs Introduction

11.3.4 Mylan Revenue in Generic Drugs Business (2018-2023)

11.3.5 Mylan Recent Development

11.4 Sun Pharmaceutical

11.4.1 Sun Pharmaceutical Company Detail

11.4.2 Sun Pharmaceutical Business Overview

11.4.3 Sun Pharmaceutical Generic Drugs Introduction

11.4.4 Sun Pharmaceutical Revenue in Generic Drugs Business (2018-2023)

11.4.5 Sun Pharmaceutical Recent Development

11.5 Aspen

11.5.1 Aspen Company Detail

11.5.2 Aspen Business Overview

11.5.3 Aspen Generic Drugs Introduction

11.5.4 Aspen Revenue in Generic Drugs Business (2018-2023)

11.5.5 Aspen Recent Development

11.6 Fresenius Kabi

11.6.1 Fresenius Kabi Company Detail

11.6.2 Fresenius Kabi Business Overview

11.6.3 Fresenius Kabi Generic Drugs Introduction

11.6.4 Fresenius Kabi Revenue in Generic Drugs Business (2018-2023)

11.6.5 Fresenius Kabi Recent Development

11.7 Pfizer (Hospira)

11.7.1 Pfizer (Hospira) Company Detail

11.7.2 Pfizer (Hospira) Business Overview

11.7.3 Pfizer (Hospira) Generic Drugs Introduction

11.7.4 Pfizer (Hospira) Revenue in Generic Drugs Business (2018-2023)

11.7.5 Pfizer (Hospira) Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Detail

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Generic Drugs Introduction

11.8.4 Sanofi Revenue in Generic Drugs Business (2018-2023)

11.8.5 Sanofi Recent Development

11.9 Aurobindo

11.9.1 Aurobindo Company Detail

11.9.2 Aurobindo Business Overview

11.9.3 Aurobindo Generic Drugs Introduction

11.9.4 Aurobindo Revenue in Generic Drugs Business (2018-2023)

11.9.5 Aurobindo Recent Development

11.10 Lupin

11.10.1 Lupin Company Detail

11.10.2 Lupin Business Overview

11.10.3 Lupin Generic Drugs Introduction

11.10.4 Lupin Revenue in Generic Drugs Business (2018-2023)

11.10.5 Lupin Recent Development

11.11 Dr. Reddy's

11.11.1 Dr. Reddy's Company Detail

11.11.2 Dr. Reddy's Business Overview

11.11.3 Dr. Reddy's Generic Drugs Introduction

11.11.4 Dr. Reddy's Revenue in Generic Drugs Business (2018-2023)

11.11.5 Dr. Reddy's Recent Development

11.12 Apotex

11.12.1 Apotex Company Detail

11.12.2 Apotex Business Overview

11.12.3 Apotex Generic Drugs Introduction

11.12.4 Apotex Revenue in Generic Drugs Business (2018-2023)

11.12.5 Apotex Recent Development

11.13 Cipla

11.13.1 Cipla Company Detail

11.13.2 Cipla Business Overview

11.13.3 Cipla Generic Drugs Introduction

11.13.4 Cipla Revenue in Generic Drugs Business (2018-2023)

11.13.5 Cipla Recent Development

11.14 ENDO (Par Pharmaceutical)

11.14.1 ENDO (Par Pharmaceutical) Company Detail

11.14.2 ENDO (Par Pharmaceutical) Business Overview

11.14.3 ENDO (Par Pharmaceutical) Generic Drugs Introduction

11.14.4 ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2018-2023)

11.14.5 ENDO (Par Pharmaceutical) Recent Development

11.15 Stada Arzneimittel

11.15.1 Stada Arzneimittel Company Detail

11.15.2 Stada Arzneimittel Business Overview

11.15.3 Stada Arzneimittel Generic Drugs Introduction

11.15.4 Stada Arzneimittel Revenue in Generic Drugs Business (2018-2023)

11.15.5 Stada Arzneimittel Recent Development

11.16 Krka Group

11.16.1 Krka Group Company Detail

11.16.2 Krka Group Business Overview

11.16.3 Krka Group Generic Drugs Introduction

11.16.4 Krka Group Revenue in Generic Drugs Business (2018-2023)

11.16.5 Krka Group Recent Development

11.17 Nichi-Iko Pharmaceutical

11.17.1 Nichi-Iko Pharmaceutical Company Detail

11.17.2 Nichi-Iko Pharmaceutical Business Overview

11.17.3 Nichi-Iko Pharmaceutical Generic Drugs Introduction

11.17.4 Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2018-2023)

11.17.5 Nichi-Iko Pharmaceutical Recent Development

11.18 Valeant

11.18.1 Valeant Company Detail

11.18.2 Valeant Business Overview

11.18.3 Valeant Generic Drugs Introduction

11.18.4 Valeant Revenue in Generic Drugs Business (2018-2023)

11.18.5 Valeant Recent Development

11.19 Zydus Cadila

11.19.1 Zydus Cadila Company Detail

11.19.2 Zydus Cadila Business Overview

11.19.3 Zydus Cadila Generic Drugs Introduction

11.19.4 Zydus Cadila Revenue in Generic Drugs Business (2018-2023)

11.19.5 Zydus Cadila Recent Development

11.20 Hikma

11.20.1 Hikma Company Detail

11.20.2 Hikma Business Overview

11.20.3 Hikma Generic Drugs Introduction

11.20.4 Hikma Revenue in Generic Drugs Business (2018-2023)

11.20.5 Hikma Recent Development

11.21 Pharmaniaga Berhad

11.21.1 Pharmaniaga Berhad Company Detail

11.21.2 Pharmaniaga Berhad Business Overview

11.21.3 Pharmaniaga Berhad Generic Drugs Introduction

11.21.4 Pharmaniaga Berhad Revenue in Generic Drugs Business (2018-2023)

11.21.5 Pharmaniaga Berhad Recent Development

11.22 Hovid Berhad

11.22.1 Hovid Berhad Company Detail

11.22.2 Hovid Berhad Business Overview

11.22.3 Hovid Berhad Generic Drugs Introduction

11.22.4 Hovid Berhad Revenue in Generic Drugs Business (2018-2023)

11.22.5 Hovid Berhad Recent Development

11.23 Duopharma Biotech

11.23.1 Duopharma Biotech Company Detail

11.23.2 Duopharma Biotech Business Overview

11.23.3 Duopharma Biotech Generic Drugs Introduction

11.23.4 Duopharma Biotech Revenue in Generic Drugs Business (2018-2023)

11.23.5 Duopharma Biotech Recent Development

11.24 Kotra Pharma

11.24.1 Kotra Pharma Company Detail

11.24.2 Kotra Pharma Business Overview

11.24.3 Kotra Pharma Generic Drugs Introduction

11.24.4 Kotra Pharma Revenue in Generic Drugs Business (2018-2023)

11.24.5 Kotra Pharma Recent Development

11.25 HOE Pharmaceutical

11.25.1 HOE Pharmaceutical Company Detail

11.25.2 HOE Pharmaceutical Business Overview

11.25.3 HOE Pharmaceutical Generic Drugs Introduction

11.25.4 HOE Pharmaceutical Revenue in Generic Drugs Business (2018-2023)

11.25.5 HOE Pharmaceutical Recent Development

11.26 Y.S.P. Industries

11.26.1 Y.S.P. Industries Company Detail

11.26.2 Y.S.P. Industries Business Overview

11.26.3 Y.S.P. Industries Generic Drugs Introduction

11.26.4 Y.S.P. Industries Revenue in Generic Drugs Business (2018-2023)

11.26.5 Y.S.P. Industries Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Generic Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Prescription

Table 3. Key Players of Non-Prescription Drugs

Table 4. Global Generic Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 5. Global Generic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Generic Drugs Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Generic Drugs Market Share by Region (2018-2023)

Table 8. Global Generic Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Generic Drugs Market Share by Region (2024-2029)

Table 10. Generic Drugs Market Trends

Table 11. Generic Drugs Market Drivers

Table 12. Generic Drugs Market Challenges

Table 13. Generic Drugs Market Restraints

Table 14. Global Generic Drugs Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Generic Drugs Market Share by Players (2018-2023)

Table 16. Global Top Generic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drugs as of 2022)

Table 17. Ranking of Global Top Generic Drugs Companies by Revenue (US$ Million) in 2022

Table 18. Global 5 Largest Players Market Share by Generic Drugs Revenue (CR5 and HHI) & (2018-2023)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Generic Drugs Product Solution and Service

Table 21. Date of Enter into Generic Drugs Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Generic Drugs Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Generic Drugs Revenue Market Share by Type (2018-2023)

Table 25. Global Generic Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Generic Drugs Revenue Market Share by Type (2024-2029)

Table 27. Global Generic Drugs Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Generic Drugs Revenue Market Share by Application (2018-2023)

Table 29. Global Generic Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Generic Drugs Revenue Market Share by Application (2024-2029)

Table 31. North America Generic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 32. North America Generic Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 33. North America Generic Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 34. Europe Generic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 35. Europe Generic Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 36. Europe Generic Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 37. Asia-Pacific Generic Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 38. Asia-Pacific Generic Drugs Market Size by Region (2018-2023) & (US$ Million)

Table 39. Asia-Pacific Generic Drugs Market Size by Region (2024-2029) & (US$ Million)

Table 40. Latin America Generic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 41. Latin America Generic Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 42. Latin America Generic Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 43. Middle East & Africa Generic Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. Middle East & Africa Generic Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 45. Middle East & Africa Generic Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 46. Teva Company Detail

Table 47. Teva Business Overview

Table 48. Teva Generic Drugs Product

Table 49. Teva Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 50. Teva Recent Development

Table 51. Novartis - Sandoz Company Detail

Table 52. Novartis - Sandoz Business Overview

Table 53. Novartis - Sandoz Generic Drugs Product

Table 54. Novartis - Sandoz Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 55. Novartis - Sandoz Recent Development

Table 56. Mylan Company Detail

Table 57. Mylan Business Overview

Table 58. Mylan Generic Drugs Product

Table 59. Mylan Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 60. Mylan Recent Development

Table 61. Sun Pharmaceutical Company Detail

Table 62. Sun Pharmaceutical Business Overview

Table 63. Sun Pharmaceutical Generic Drugs Product

Table 64. Sun Pharmaceutical Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 65. Sun Pharmaceutical Recent Development

Table 66. Aspen Company Detail

Table 67. Aspen Business Overview

Table 68. Aspen Generic Drugs Product

Table 69. Aspen Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 70. Aspen Recent Development

Table 71. Fresenius Kabi Company Detail

Table 72. Fresenius Kabi Business Overview

Table 73. Fresenius Kabi Generic Drugs Product

Table 74. Fresenius Kabi Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 75. Fresenius Kabi Recent Development

Table 76. Pfizer (Hospira) Company Detail

Table 77. Pfizer (Hospira) Business Overview

Table 78. Pfizer (Hospira) Generic Drugs Product

Table 79. Pfizer (Hospira) Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 80. Pfizer (Hospira) Recent Development

Table 81. Sanofi Company Detail

Table 82. Sanofi Business Overview

Table 83. Sanofi Generic Drugs Product

Table 84. Sanofi Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 85. Sanofi Recent Development

Table 86. Aurobindo Company Detail

Table 87. Aurobindo Business Overview

Table 88. Aurobindo Generic Drugs Product

Table 89. Aurobindo Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 90. Aurobindo Recent Development

Table 91. Lupin Company Detail

Table 92. Lupin Business Overview

Table 93. Lupin Generic Drugs Product

Table 94. Lupin Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 95. Lupin Recent Development

Table 96. Dr. Reddy's Company Detail

Table 97. Dr. Reddy's Business Overview

Table 98. Dr. Reddy's Generic Drugs Product

Table 99. Dr. Reddy's Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 100. Dr. Reddy's Recent Development

Table 101. Apotex Company Detail

Table 102. Apotex Business Overview

Table 103. Apotex Generic Drugs Product

Table 104. Apotex Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 105. Apotex Recent Development

Table 106. Cipla Company Detail

Table 107. Cipla Business Overview

Table 108. Cipla Generic Drugs Product

Table 109. Cipla Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 110. Cipla Recent Development

Table 111. ENDO (Par Pharmaceutical) Company Detail

Table 112. ENDO (Par Pharmaceutical) Business Overview

Table 113. ENDO (Par Pharmaceutical) Generic Drugs Product

Table 114. ENDO (Par Pharmaceutical) Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 115. ENDO (Par Pharmaceutical) Recent Development

Table 116. Stada Arzneimittel Company Detail

Table 117. Stada Arzneimittel Business Overview

Table 118. Stada Arzneimittel Generic Drugs Product

Table 119. Stada Arzneimittel Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 120. Stada Arzneimittel Recent Development

Table 121. Krka Group Company Detail

Table 122. Krka Group Business Overview

Table 123. Krka Group Generic Drugs Product

Table 124. Krka Group Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 125. Krka Group Recent Development

Table 126. Nichi-Iko Pharmaceutical Company Detail

Table 127. Nichi-Iko Pharmaceutical Business Overview

Table 128. Nichi-Iko Pharmaceutical Generic Drugs Product

Table 129. Nichi-Iko Pharmaceutical Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 130. Nichi-Iko Pharmaceutical Recent Development

Table 131. Valeant Company Detail

Table 132. Valeant Business Overview

Table 133. Valeant Generic Drugs Product

Table 134. Valeant Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 135. Valeant Recent Development

Table 136. Zydus Cadila Company Detail

Table 137. Zydus Cadila Business Overview

Table 138. Zydus Cadila Generic Drugs Product

Table 139. Zydus Cadila Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 140. Zydus Cadila Recent Development

Table 141. Hikma Company Detail

Table 142. Hikma Business Overview

Table 143. Hikma Generic Drugs Product

Table 144. Hikma Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 145. Hikma Recent Development

Table 146. Pharmaniaga Berhad Company Detail

Table 147. Pharmaniaga Berhad Business Overview

Table 148. Pharmaniaga Berhad Generic Drugs Product

Table 149. Pharmaniaga Berhad Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 150. Pharmaniaga Berhad Recent Development

Table 151. Hovid Berhad Company Detail

Table 152. Hovid Berhad Business Overview

Table 153. Hovid Berhad Generic Drugs Product

Table 154. Hovid Berhad Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 155. Hovid Berhad Recent Development

Table 156. Duopharma Biotech Company Detail

Table 157. Duopharma Biotech Business Overview

Table 158. Duopharma Biotech Generic Drugs Product

Table 159. Duopharma Biotech Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 160. Duopharma Biotech Recent Development

Table 161. Kotra Pharma Company Detail

Table 162. Kotra Pharma Business Overview

Table 163. Kotra Pharma Generic Drugs Product

Table 164. Kotra Pharma Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 165. Kotra Pharma Recent Development

Table 166. HOE Pharmaceutical Company Detail

Table 167. HOE Pharmaceutical Business Overview

Table 168. HOE Pharmaceutical Generic Drugs Product

Table 169. HOE Pharmaceutical Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 170. HOE Pharmaceutical Recent Development

Table 171. Y.S.P. Industries Company Detail

Table 172. Y.S.P. Industries Business Overview

Table 173. Y.S.P. Industries Generic Drugs Product

Table 174. Y.S.P. Industries Revenue in Generic Drugs Business (2018-2023) & (US$ Million)

Table 175. Y.S.P. Industries Recent Development

Table 176. Research Programs/Design for This Report

Table 177. Key Data Information from Secondary Sources

Table 178. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Generic Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global Generic Drugs Market Share by Type: 2022 VS 2029

Figure 3. Prescription Features

Figure 4. Non-Prescription Drugs Features

Figure 5. Global Generic Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 6. Global Generic Drugs Market Share by Application: 2022 VS 2029

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Others Case Studies

Figure 10. Generic Drugs Report Years Considered

Figure 11. Global Generic Drugs Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Generic Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Generic Drugs Market Share by Region: 2022 VS 2029

Figure 14. Global Generic Drugs Market Share by Players in 2022

Figure 15. Global Top Generic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drugs as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Generic Drugs Revenue in 2022

Figure 17. North America Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Generic Drugs Market Share by Country (2018-2029)

Figure 19. United States Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. Canada Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 21. Europe Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Europe Generic Drugs Market Share by Country (2018-2029)

Figure 23. Germany Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. France Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. U.K. Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. Italy Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. Russia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Nordic Countries Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Asia-Pacific Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Asia-Pacific Generic Drugs Market Share by Region (2018-2029)

Figure 31. China Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Japan Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. South Korea Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Southeast Asia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. India Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Australia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Latin America Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Latin America Generic Drugs Market Share by Country (2018-2029)

Figure 39. Mexico Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Brazil Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. Middle East & Africa Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Middle East & Africa Generic Drugs Market Share by Country (2018-2029)

Figure 43. Turkey Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Saudi Arabia Generic Drugs Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Teva Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 46. Novartis - Sandoz Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 47. Mylan Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 48. Sun Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 49. Aspen Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 50. Fresenius Kabi Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 51. Pfizer (Hospira) Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 52. Sanofi Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 53. Aurobindo Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 54. Lupin Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 55. Dr. Reddy's Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 56. Apotex Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 57. Cipla Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 58. ENDO (Par Pharmaceutical) Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 59. Stada Arzneimittel Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 60. Krka Group Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 61. Nichi-Iko Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 62. Valeant Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 63. Zydus Cadila Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 64. Hikma Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 65. Pharmaniaga Berhad Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 66. Hovid Berhad Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 67. Duopharma Biotech Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 68. Kotra Pharma Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 69. HOE Pharmaceutical Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 70. Y.S.P. Industries Revenue Growth Rate in Generic Drugs Business (2018-2023)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Generic Drugs Market Research Report 2023

Published Date: January 2023

Report Code: QYRE-Auto-32W9027

Global Generic Drugs Market Research Report 2023

FEATURED COMPANIES

Generic Drugs Market Size

Generic Drugs Market

Report Scope

Scope of Generic Drugs Market Report

Core Chapters

FAQ for this report

How fast is Generic Drugs Market market growing?

What is the Generic Drugs Market market size in 2029?

FEATURED COMPANIES